Holland Venture launches new fund at the MedtechPartners meeting and invests in LivAssured

Investment company Holland Venture invests with OostNL and Health Innovations Fund in LivAssured, which developed the revolutionary NightWatch in collaboration with neurologists and patient associations. Jan-Frens van Giessel (Investment Director Holland Venture) and Asmund Tielens (CTO LivAssured) announced this news at the 3rd MedtechPartners meeting of 2018. Remarkable detail: December 2017 LivAssured pitched at the MedtechPartners meeting with funding as one of the help questions.

The NightWatch supports  the care task of parents and healthcare professionals by giving off a warning in the event of a heavy night-time epileptic seizure. Because of the NightWatch, help can be provided quickly and adequately, reducing the risk of medical complications. The investment enables further development and the international roll-out of the NightWatch. With the investment in LivAssured, Holland Venture officially launched the Holland Venture Healthcare Innovation Fund II.

With this second Healthcare Innovation Fund, Holland Venture provides growth capital to promising Dutch entrepreneurs in the healthcare market. The fund, with a size of 14 million euros, has set itself the goal of building a portfolio of around 10 investments within the segment’s devices, diagnostics, and digital health.